PROVIDER PROFILE · NPI 1811190598

Tabor FlickingerM.D.

Internal MedicineOrange, VAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

265

Unique beneficiaries

—

Total services

382

Distinct HCPCS

Medicare payment

$22K

Peer benchmark

Total Medicare services vs. 2,091 Internal Medicine providers in VA — below median (cohort median 769).

PRESCRIBING · PART D · 2024

Total Rx claims

3,522

Beneficiaries

—

Total drug cost

$241K

Distinct drugs

Brand share

19.1%

Top prescribed drugs

Amlodipine Besylate170 claims

Atorvastatin Calcium159 claims

Lisinopril146 claims

Gabapentin138 claims

Hydrochlorothiazide129 claims

QUALITY · MIPS · 2024

Final MIPS score

86.5

Quality

79.8

Cost

75.1

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.48%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Tabor Flickinger's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Zia Roshandel Cardiology · Culpeper, VA	21	98
Blake Garmon Internal Medicine · Shamokin Dam, PA	18	97
MARTHA JEFFERSON HOSPITAL	14	54
RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA	12	36
Ionut Mosteanu Internal Medicine · Ridgefield, CT	11	70
SEFCZEK, ROBERT	11	24
Evelyn Bargmann Internal Medicine · Charlottesville, VA	11	48

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history